KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 76 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $17,643,000 | -39.9% | 1,151,622 | 0.0% | 1.02% | -51.5% |
Q2 2020 | $29,343,000 | +149.7% | 1,151,622 | +51.7% | 2.10% | +97.7% |
Q1 2020 | $11,750,000 | +2.9% | 759,050 | -10.0% | 1.06% | -0.6% |
Q2 2019 | $11,421,000 | -25.0% | 843,478 | 0.0% | 1.07% | -29.6% |
Q1 2019 | $15,233,000 | +104.7% | 843,478 | +218.4% | 1.52% | +59.9% |
Q4 2018 | $7,440,000 | +10.2% | 264,878 | 0.0% | 0.95% | +39.5% |
Q3 2018 | $6,754,000 | +109.2% | 264,878 | +42.4% | 0.68% | +63.7% |
Q2 2018 | $3,228,000 | – | 186,073 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |